Miyata, Y., Asai, A., Mitsunari, K., Matsuo, T., Ohba, K., & Sakai, H. (2015). Safety and efficacy of combination therapy with low-dose gemcitabine, paclitaxel, and sorafenib in patients with cisplatin-resistant urothelial cancer. Med Oncol.
Citação norma ChicagoMiyata, Yasuyoshi, Akihiro Asai, Kensuke Mitsunari, Tomohiro Matsuo, Kojiro Ohba, and Hideki Sakai. "Safety and Efficacy of Combination Therapy With Low-dose Gemcitabine, Paclitaxel, and Sorafenib in Patients With Cisplatin-resistant Urothelial Cancer." Med Oncol 2015.
Citação norma MLAMiyata, Yasuyoshi, et al. "Safety and Efficacy of Combination Therapy With Low-dose Gemcitabine, Paclitaxel, and Sorafenib in Patients With Cisplatin-resistant Urothelial Cancer." Med Oncol 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.